CCL2 and Hepatic fibrosis: In a mouse model of liver fibrosis, CCL2 inhibitors prevented Ly-6Chi monocytes from entering the liver, thus indirectly increasing Ly-6Clo monocytes, and liver fibrosis was shown to significantly decrease [139].